Pfizer Inc. (PFE)
Could Pfizer Become a Top Weight Loss Drug Stock? Don't Count on It.
Pfizer doesn't currently produce any anti-obesity medicines, but it wants to do so. However, its most mature program on that front isn't exactly a sizzler.
Pfizer Stock Nears Golden Cross, Signals Potential Upside With Strong Oncology Portfolio
Pfizer Inc PFE, one of the world's largest pharmaceutical firms, is on the verge of a bullish Golden Cross, a significant technical indicator suggesting potential upward momentum for the stock.
Zacks Industry Outlook Eli Lilly, Novo Nordisk, Merck and Pfizer
Eli Lilly, Novo Nordisk, Merck and Pfizer have been highlighted in this Industry Outlook article.
Wall St Veteran Names Worst Value Trap in the World
Lee and I have a list of stocks we love to hate, and one of Lee's picks is Pfizer (NYSE: PFE).
Nvidia, Pfizer lead $80 mln funding for Israeli medical AI tech firm CytoReason
Israel's CytoReason, which uses AI to develop disease models, said on Wednesday it had raised $80 million in a private funding round.
European Commission didn't provide enough information about COVID-19 vaccine deals, EU court says
The European Commission did not allow the public enough access to information about COVID-19 vaccine purchase agreements it secured with pharmaceutical companies during the pandemic, the EU general court said Wednesday.
Forget Medical Properties Trust: This High-Yielding Dividend Stock Is a Much Better Buy
Medical Properties Trust pays investors a high yield, but the stock carries significant risk. Pfizer's more modest yield of 6% is still well above average, and the dividend has been increasing in recent years.
Pfizer (PFE) Exceeds Market Returns: Some Facts to Consider
Pfizer (PFE) reachead $29.10 at the closing of the latest trading day, reflecting a +0.62% change compared to its last close.
Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
PFE or NVO: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Large Cap Pharmaceuticals sector have probably already heard of Pfizer (PFE) and Novo Nordisk (NVO). But which of these two stocks offers value investors a better bang for their buck right now?
With Oral Anti-Obesity Candidate Development, Pfizer Seeks Relevant And Competitive Presence - Goldman Sachs
Thursday, Pfizer Inc PFE announced it selected its preferred once-daily modified release formulation for danuglipron, an oral glucagon-like peptide-1 (GLP-1) receptor agonist.
Pfizer (PFE) Moves Forward With Once-Daily Obesity Pill Study
Pfizer (PFE) is set to move forward with the development of a once-daily formulation of danuglipron, its GLP-1 candidate for obesity.
